Cooley: Illegality Doctrine Rejected in Legal Cannabis Patent Case, Confirming Patent Enforceability
Cooley Alert February 13, 2023 As the industry for cannabis that is legal under state and/or federal law continues to expand, a flurry of court cases in recent years have addressed whether these businesses can utilize the federal courts to vindicate their legal...
Arnold & Porter: United States: FDA Announces A Path Forward For CBD Consumer Products: A New Regulatory Framework Is Needed
13 February 2023 by Howard Sklamberg (Washington, DC) and Elizabeth Trentacost (Washington, DC) Arnold & Porter Cannabis industry stakeholders waiting for the US Food and Drug Administration (FDA) to forge a regulatory path forward for cannabidiol (CBD) in...
Stark & Stark: Interstate Cannabis Commerce on the Horizon Thanks to California
By Gene Markin on February 10, 2023 Despite the proliferation of in-state cannabis businesses and commerce, the sale and transportation of marijuana between and among states, even states with legal cannabis frameworks, remains federally prohibited due to the...
Aird Bellis: Quebec Court Dismisses Proposed Class Action Against Cannabis Company
03 February 2023 bySimon Dugas (Toronto) andSteve J. Tenai (Toronto) Aird & Berlis LLP On January 23, 2023, the Quebec Superior Court denied leave to pursue a class action against HEXO Corp. The proposed class action raised various allegations of misrepresentation...
Michael Sassano & Antonio Guedelha: GMP# 17: GMP Market Forecasting and Budget Management
Authored By: Michael Sassano & Antonio Guedelha The process of forecasting is complex when you want to bring a new medicine to market. GMP processes are slow and have an intense workload for documentation of new products that depend on the country...Top 200 Cannabis Lawyers
We Support